Robert Renninger, Chief Financial Officer at Athira Pharma, Inc. (ATHA), sold 297 shares at $6.88 ($2K) on 2026-01-02, disclosed to the SEC on 2026-01-05.
Open-market sale of $2k ATHA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ATHA | SELL | 2025-01-03 | $2K | — | Filing → |